Artal Group S.A. Scholar Rock Holding Corp Put Options Transaction History
Artal Group S.A.
- $1.58 Billion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding SRRK
# of Institutions
172Shares Held
75.4MCall Options Held
151KPut Options Held
40.1K-
Price T Rowe Associates Inc Baltimore, MD8.19MShares$245 Million0.01% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$204 Million29.08% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$170 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA5.45MShares$163 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$115 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.55B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...